AstraZeneca COVID-19 Vaccine Information

Disclaimer: The information on this page is intended for Vaccine Recipients only.

Special Approval of medicinal products during public health emergency or pandemic situation for COVID-19 vaccine by AstraZeneca has been granted by the Brunei Darussalam Medicines Control Authority. As with any new medicine in Brunei Darussalam, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Please refer to your Healthcare Provider for further information, or you can contact the AstraZeneca Medical Information team here.

Medical Information Inquiries

Reporting of Suspected Adverse Reactions

Vaccine Recipient page: If you notice any side effects, please inform your healthcare provider. You can also report side effects directly via the national reporting system through the Bruhealth app or the Symptoms After COVID-19 Vaccination Reporting Form available from vaccination sites or at the nearest government pharmacy (hospital/health centre). The completed Symptoms after COVID-19 vaccination reporting form should be returned to the nearest government pharmacy (hospital/health centre) or e-mail at nadrmc.dps@moh.gov.bn.